Study S000094

Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02584075
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: UNKNOWN
Enrollment: 100
Start: 2015-11
Primary completion: 2017-11
Lead sponsor: Beijing Chao Yang Hospital
Conditions: Coronary Endothelial Function
Interventions: DRUG:Byetta (Exenatide); DRUG:Glucophage ( Metformin Hydrochloride)
Results posted: FALSE

Registered primary outcomes

Coronary endothelial function [the change of coronary endothelial function(baseline, 12 weeks)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.